During the past decade, Cardiovascular Research, LLC conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Research, LLC" #1 collaborator was "Daiichi Sankyo, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Research, LLC" are "Coronary Artery Disease" (3 trials). Many other conditions were trialed in "Cardiovascular Research, LLC" in a lesser frequency.

Most popular intervention types in "Cardiovascular Research, LLC" are "Device" (3 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "3 months of dual antiplatelet therapy (DAPT)" (1 trials), "Aspirin" (1 trials), "P2Y12 antagonist" (1 trials), "PROMUS Element Plus Coronary Stent System" (1 trials) and "SYNERGY Stent System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Research, LLC" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Research, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cardiovascular Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Research, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".